FRASYCE Trademark

Trademark Overview

On Thursday, June 18, 2020, a trademark application was filed for FRASYCE with the United States Patent and Trademark Office. The USPTO has given the FRASYCE trademark a serial number of 90009730. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 24, 2023. This trademark is owned by ImmunoGen, Inc.. The FRASYCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
frasyce

General Information

Serial Number90009730
Word MarkFRASYCE
Filing DateThursday, June 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunoGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunoGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 24, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 9, 2022SOU EXTENSION 3 GRANTED
Friday, December 9, 2022SOU EXTENSION 3 FILED
Friday, December 9, 2022TEAS EXTENSION RECEIVED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2022SOU EXTENSION 2 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 2 FILED
Tuesday, June 14, 2022TEAS EXTENSION RECEIVED
Wednesday, December 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 13, 2021SOU EXTENSION 1 GRANTED
Monday, December 13, 2021SOU EXTENSION 1 FILED
Monday, December 13, 2021TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Monday, September 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 21, 2020NON-FINAL ACTION E-MAILED
Monday, September 21, 2020NON-FINAL ACTION WRITTEN
Monday, September 21, 2020ASSIGNED TO EXAMINER
Thursday, July 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 22, 2020NEW APPLICATION ENTERED

Related Keywords

frasyce preparations pharmaceuticals pharmaceutical treatment namely human disorders conditions oncological cancer